Published in Mem Inst Oswaldo Cruz on December 11, 2015
A Universal Vaccine against Leptospirosis: Are We Going in the Right Direction? Front Immunol (2017) 0.75
Immunoprotective properties of recombinant LigA and LigB in a hamster model of acute leptospirosis. PLoS One (2017) 0.75
Leptospira and leptospirosis. Vet Microbiol (2009) 4.99
Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat Rev Microbiol (2009) 3.94
Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis (2005) 2.75
Vaccine adjuvants: current state and future trends. Immunol Cell Biol (2004) 2.74
Leptospirosis-associated severe pulmonary hemorrhagic syndrome, Salvador, Brazil. Emerg Infect Dis (2008) 2.61
Emergence, control and re-emerging leptospirosis: dynamics of infection in the changing world. Clin Microbiol Infect (2011) 2.58
Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily. Mol Microbiol (2003) 2.53
Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen. Infect Immun (2007) 2.12
Heterologous prime-boost vaccination. Curr Opin Immunol (2009) 1.84
A high-copy T7 Escherichia coli expression vector for the production of recombinant proteins with a minimal N-terminal His-tagged fusion peptide. Braz J Med Biol Res (2004) 1.72
Leptospiral immunoglobulin-like proteins elicit protective immunity. Vaccine (2004) 1.58
Osmolarity, a key environmental signal controlling expression of leptospiral proteins LigA and LigB and the extracellular release of LigA. Infect Immun (2005) 1.52
The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine (2007) 1.49
Repeated domains of leptospira immunoglobulin-like proteins interact with elastin and tropoelastin. J Biol Chem (2009) 1.37
Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1. Infect Immun (2005) 1.31
Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters. Vaccine (2007) 1.28
Genetic diversity of the Leptospiral immunoglobulin-like (Lig) genes in pathogenic Leptospira spp. Infect Genet Evol (2008) 1.21
Leptospiral immunoglobulin-like proteins interact with human complement regulators factor H, FHL-1, FHR-1, and C4BP. J Infect Dis (2012) 1.21
The C-terminal variable domain of LigB from Leptospira mediates binding to fibronectin. J Vet Sci (2008) 1.20
Immunogenicity and protective efficacy of recombinant Leptospira immunoglobulin-like protein B (rLigB) in a hamster challenge model. Microbes Infect (2008) 1.18
Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge. Vaccine (2007) 1.17
Leptospirosis vaccines: past, present, and future. J Postgrad Med (2005) 1.11
Recombinant vaccines against leptospirosis. Hum Vaccin (2011) 1.08
Recombinant subunit vaccines: potentials and constraints. Dev Biol (Basel) (2005) 1.05
Heterologous expression of pathogen-specific genes ligA and ligB in the saprophyte Leptospira biflexa confers enhanced adhesion to cultured cells and fibronectin. BMC Microbiol (2011) 0.99
Immune response and prophylactic efficacy of smegmosomes in a hamster model of leptospirosis. Vaccine (2009) 0.95
A LigA three-domain region protects hamsters from lethal infection by Leptospira interrogans. PLoS Negl Trop Dis (2011) 0.92
An imprint method for detecting leptospires in the hamster model of vaccine-mediated immunity for leptospirosis. J Med Microbiol (2009) 0.92
Subunit approach to evaluation of the immune protective potential of leptospiral antigens. Clin Vaccine Immunol (2011) 0.91
Codelivery of a DNA vaccine and a protein vaccine with aluminum phosphate stimulates a potent and multivalent immune response. J Mol Med (Berl) (2003) 0.91
Multiple activities of LigB potentiate virulence of Leptospira interrogans: inhibition of alternative and classical pathways of complement. PLoS One (2012) 0.91
Identification and characterization of OmpA-like proteins as novel vaccine candidates for Leptospirosis. Vaccine (2010) 0.89
Protection of guinea pigs against Leptospira interrogans serovar Lai by LipL21 DNA vaccine. Cell Mol Immunol (2008) 0.85
Immune strategies using single-component LipL32 and multi-component recombinant LipL32-41-OmpL1 vaccines against leptospira. Braz J Med Biol Res (2009) 0.83
A conserved region of leptospiral immunoglobulin-like A and B proteins as a DNA vaccine elicits a prophylactic immune response against leptospirosis. Clin Vaccine Immunol (2013) 0.83
Mannosylated LigANI produced in Pichia pastoris protects hamsters against leptospirosis. Curr Microbiol (2013) 0.82
Leptosome-entrapped leptospiral antigens conferred significant higher levels of protection than those entrapped with PC-liposomes in a hamster model. Vaccine (2009) 0.82
Nucleic acid vaccines: research tool or commercial reality. Vet Immunol Immunopathol (2000) 0.82
A Leptospira borgpetersenii serovar Hardjo vaccine induces a Th1 response, activates NK cells, and reduces renal colonization. Clin Vaccine Immunol (2011) 0.81
Characterization of a virulent Leptospira interrogans strain isolated from an abandoned swimming pool. Braz J Microbiol (2013) 0.80
Recent developments in veterinary vaccinology. Vet J (2005) 0.80
A prime-boost strategy using the novel vaccine candidate, LemA, protects hamsters against leptospirosis. Clin Vaccine Immunol (2013) 0.80
High yield expression of leptospirosis vaccine candidates LigA and LipL32 in the methylotrophic yeast Pichia pastoris. Microb Cell Fact (2010) 0.79